Psychotic disorders (e.g., schizophrenia, schizoaffective disorder) and mood disorders (e.g., bipolar disorder, major depression) are known to share genetic vulnerabilities and environmental risk factors that affect brain function and cognition. Our multidisciplinary approach to understanding the stress-related neurobiology of these severe and disabling psychiatric conditions sees collaboration among experts in cognition, neuroimaging, genetics, and bioinformatics working together on a number of specific projects which are listed below according to funding received.
More than 80,000 people are living with Parkinson’s disease in Australia, and of these, approximately two thirds will fall each year. Ensuing injuries, hospitalisations, fear of falling and caregiver burden are devastating, widespread and costly. As the prevalence of Parkinson’s disease will double between 2010 and 2040, the associated human and economic burden will also grow. Innovative therapies to improve […]